NCT03844607

Brief Summary

Behavioral changes following a traumatic brain injury (TBI) are one of the biggest challenges for patients, as well as their family members and others involved in their recovery. One of the most common behavioral changes following TBI is the emergence of impulsive behavior, which has been associated with destructive, suicidal, and aggressive behavior, and is related to poor rehabilitation program adherence. The primary objective of this study is to investigate the effect of a novel neuroplasticity based intervention that combines cognitive training and transcranial direct current stimulation (tDCS) to reduce impulsivity and to improve outcomes and quality of life for those who have suffered a TBI.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 8, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 13, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 18, 2019

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 16, 2023

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

4.2 years

First QC Date

February 13, 2019

Last Update Submit

March 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Barratt Impulsiveness Scale (BIS)

    Differences in magnitude of change in BIS scores between active tDCS and sham groups from baseline to follow-up sessions. Higher total score on the BIS indicates higher levels of impulsivity.

    Change between baseline and 1 week follow-up; 1, 2, and 3 months following intervention

Secondary Outcomes (2)

  • Change in choice of higher risk option in the Risk Task

    Change between baseline and 1 week follow-up; 1, 2, and 3 months following intervention

  • Change in Brain Functional Connectivity as measured by functional magnetic resonance imaging (fMRI)

    Change between baseline and 1 week follow-up

Study Arms (2)

Active tDCS

EXPERIMENTAL

Participants will receive 5 sessions of cognitive training concurrent with transcranial direct current stimulation (anode over left frontal cortex, cathode over right frontal cortex; 2 mAmps for 20 minutes).

Device: Active Transcranial Direct Current Stimulation (tDCS)

Sham tDCS

SHAM COMPARATOR

Participants will receive 5 sessions of cognitive training concurrent with sham tDCS. For sham tDCS, electrodes are placed at the same locations as for active tDCS, but current is ramped up for the initial 30 secs, then immediately ramped back down. This method mimics the initial physical sensation of stimulation, but there is no active current for the remainder of the session.

Device: Sham Transcranial Direct Current Stimulation (tDCS)

Interventions

Cognitive training concurrent with 2 mAmps of anodal stimulation applied to the left frontal cortex for 20 minutes.

Active tDCS

Cognitive training concurrent with sham tDCS (30 secs ramp up/ramp down of current at beginning of session).

Sham tDCS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be included in the study if they:
  • have a clinical history of impulsive behavior, including substance abuse, gambling problems, legal issues such as DUI, violent acts, aggression, history of suicidality, or ADHD as assessed by the patient's clinical provider and/or screen of medical records
  • are age 18 or older
  • are receiving services from the Minneapolis VA Health Care System
  • are stable on any medications for at least 1 week at the baseline visit
  • have a diagnosis of mild, moderate, or severe TBI (as defined by VA/DoD Clinical Practice Guidelines criteria)

You may not qualify if:

  • Persons will be excluded from this study if they:
  • have a significant neurological disorder based on the Principal Investigators judgment that would impact risk
  • diagnosed with current active psychosis or mania
  • have metallic cranial plates/screws or implanted devices
  • have eczema on scalp or other scalp lesions or skin disorders that may become irritated by stimulation
  • are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minneapolis VA Medical Center

Minneapolis, Minnesota, 55417, United States

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticImpulsive Behavior

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

February 13, 2019

First Posted

February 18, 2019

Study Start

January 8, 2019

Primary Completion

March 16, 2023

Study Completion

January 1, 2025

Last Updated

March 13, 2024

Record last verified: 2024-03

Locations